Cite

HARVARD Citation

    Kranawetter, M. et al. (2018). Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published Data. International journal of gynecological cancer. 28 (6), pp. 1196-1202. [Online]. 
  
Back to record